Sandeep Kumar Jha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sandeep Kumar Jha has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Shweta Panwar
Centre for Biomedical Engineering, Indian Institute of Technology Delhi, New Delhi 110016, India
2 shared publications Akanksha Priya
Department of Laboratory Medicine, All India Institute of Medical Sciences, New Delhi, 110029, India
1 shared publication- Amit Kumar Singh
Department of Biomedical Engineering, Vignan's Foundation for Science, Technology & Research, Vadlamudi, Guntur. Andhra Pradesh, India
1 shared publication D. Syed Kasim
Centre for Biomedical Engineering, Indian Institute of Technology Delhi, New Delhi, 110016, India
1 shared publicationHarpreet Singh
Centre for Biomedical Engineering, Indian Institute of Technology Delhi, New Delhi, 110016, India
1 shared publicationK. K. Deepak
Centre for Biomedical Engineering, Indian Institute of Technology Delhi, New Delhi, 110016, India
1 shared publication
Latest Publications
- Open Access
- 18 November 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (53) , 45607-45618
A multivariate biosensor for non-invasive glucose and urea monitoring via saliva
Non-communicable diseases such as diabetes and chronic kidney disease (CKD) are major global health concerns due to associated high morbidity rates. Conventional monitoring of these diseases typically involves invasive methods, which can be painful and inconvenient for patients. This study highlights the development of a non-invasive, handheld optical biosensor capable of multivariate analysis using saliva samples. The device used two distinct paper-fluidic strips designed with different enzyme–dye combinations to detect glucose and urea. The biosensor also used ambient temperature compensation to address the differential sensitivity of these sensors owing to variations caused by temperature-dependent enzyme kinetics, thereby enhancing the measurement accuracy. Biosensor characteristics with the glucose oxidase-based strip showed a sensitivity of 1.93 count per mg per dL, linearity range from 8 to 358 mg dL−1, limit of detection (LOD) of 8 mg dL−1, and response time of 7.35 s. The clinical validation shows good correlation between saliva glucose levels (SGLs) and blood glucose levels (BGLs). The urea biosensor strip shows a sensitivity of 1.51 count per mg per dL, LOD of 5 mg dL−1, linearity range from 5 to 90 mg dL−1, and response time of 3 s. The clinical validation for the CKD patient shows a significant correlation between blood urea levels and saliva urea levels. The results demonstrate that the device offers a rapid, reliable, and user-friendly alternative for point-of-care testing (POCT), potentially improving patient compliance and management of diabetes and CKD. Significance: The findings suggest that this technology could represent a significant advancement in non-invasive diagnostic tools and can be used as a POCT by chronic patients.
- 18 November 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (53) , 45607-45618
Open AccessA multivariate biosensor for non-invasive glucose and urea monitoring via saliva
Non-communicable diseases such as diabetes and chronic kidney disease (CKD) are major global health concerns due to associated high morbidity rates. Conventional monitoring of these diseases typically involves invasive methods, which can be painful and inconvenient for patients. This study highlights the development of a non-invasive, handheld optical biosensor capable of multivariate analysis using saliva samples. The device used two distinct paper-fluidic strips designed with different enzyme–dye combinations to detect glucose and urea. The biosensor also used ambient temperature compensation to address the differential sensitivity of these sensors owing to variations caused by temperature-dependent enzyme kinetics, thereby enhancing the measurement accuracy. Biosensor characteristics with the glucose oxidase-based strip showed a sensitivity of 1.93 count per mg per dL, linearity range from 8 to 358 mg dL−1, limit of detection (LOD) of 8 mg dL−1, and response time of 7.35 s. The clinical validation shows good correlation between saliva glucose levels (SGLs) and blood glucose levels (BGLs). The urea biosensor strip shows a sensitivity of 1.51 count per mg per dL, LOD of 5 mg dL−1, linearity range from 5 to 90 mg dL−1, and response time of 3 s. The clinical validation for the CKD patient shows a significant correlation between blood urea levels and saliva urea levels. The results demonstrate that the device offers a rapid, reliable, and user-friendly alternative for point-of-care testing (POCT), potentially improving patient compliance and management of diabetes and CKD. Significance: The findings suggest that this technology could represent a significant advancement in non-invasive diagnostic tools and can be used as a POCT by chronic patients.
- Open Access
- 30 May 2025
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 4 (8) , 680-689
A non-invasive device for glucose monitoring through saliva – a paradigm shift in diabetes care
A portable bienzymatic biosensor enables rapid, non-invasive quantification of salivary glucose through colorimetric detection and derivative analysis for point-of-care diagnostics.
- 30 May 2025
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 4 (8) , 680-689
Open AccessA non-invasive device for glucose monitoring through saliva – a paradigm shift in diabetes care
A portable bienzymatic biosensor enables rapid, non-invasive quantification of salivary glucose through colorimetric detection and derivative analysis for point-of-care diagnostics.